SYAHRANI, R. A.; LOUISA, M.; WANANDI, S. I. SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS. Int J App Pharm 2019, 11, 91-96.